Chronic kidney disease affects an estimated 37 million Americans—roughly 15 percent of the adult population—and the vast majority don't know they have it. CKD develops silently, often producing no symptoms until significant kidney function has already been lost. By the time people notice changes in how they feel, they may have already progressed to an advanced stage where treatment options narrow and the trajectory toward kidney failure becomes harder to reverse.
Understanding CKD staging isn't just an academic exercise. It's a practical framework that tells you exactly where you stand, what risks you face, what you should be doing to protect your kidneys at each stage, and when critical decisions about treatment need to be made. The staging system provides a roadmap that transforms a frightening diagnosis into a structured plan.
How CKD Staging Works
CKD staging is based primarily on your glomerular filtration rate (GFR)—a measurement of how much blood your kidneys filter per minute. Your kidneys contain approximately one million tiny filtering units called nephrons, each containing a glomerulus that separates waste products from blood. The GFR quantifies how efficiently these glomeruli are working.
A healthy GFR is typically above 90 mL/min/1.73m², meaning your kidneys filter at least 90 milliliters of blood per minute after adjusting for body surface area. As nephrons are damaged or destroyed by disease, the surviving nephrons compensate by working harder—for a while. Eventually, the overall filtration capacity declines, and GFR drops.
GFR is most commonly estimated (eGFR) from a blood test measuring creatinine—a waste product from muscle metabolism that the kidneys filter at a relatively constant rate. When kidney function declines, creatinine accumulates in the blood, and the eGFR calculation translates this creatinine level into an estimate of kidney function that accounts for age, sex, and race.
The five CKD stages, along with their corresponding GFR ranges, paint a progressively more serious picture of kidney health.
Stage 1: Kidney Damage With Normal Function (GFR 90 or above)
Stage 1 CKD means your kidneys are damaged but still filtering blood at a normal rate. This seems paradoxical—how can you have kidney disease with normal function? The answer is that kidney damage and kidney function are related but distinct concepts. You can have structural damage (detectable through urine tests, imaging, or biopsy) before that damage is severe enough to reduce overall filtration.
Stage 1 is typically identified through persistent proteinuria (protein in the urine, particularly albumin), hematuria (blood in the urine from kidney sources), or abnormal kidney imaging showing structural changes such as polycystic kidneys, renal scarring, or reflux nephropathy.
What you'll notice: Almost certainly nothing. Stage 1 CKD produces no symptoms. It's detected incidentally during routine screening or testing for other conditions.
What's happening: The kidneys are compensating for early damage. Remaining healthy nephrons are working harder to maintain normal filtration. This compensation masks the damage on standard blood tests—creatinine and GFR appear normal because the increased workload of healthy nephrons offsets the lost function of damaged ones.
What you should do: This is the intervention sweet spot. Identifying and treating the underlying cause of kidney damage at this stage can halt progression entirely in many cases. Key actions include controlling blood pressure (target below 130/80 mmHg as recommended by KDIGO guidelines), managing diabetes if present (target HbA1c below 7 percent), eliminating nephrotoxic medications (NSAIDs, certain antibiotics, excessive contrast dye), and addressing any urinary tract abnormalities. An ACE inhibitor or ARB should be prescribed if proteinuria is present, as these medications protect the glomeruli from pressure-related damage even in normotensive patients.
Stage 2: Kidney Damage With Mild Function Loss (GFR 60-89)
Stage 2 represents the first measurable decline in kidney function. GFR has dropped below normal, but the kidneys are still functioning well enough that waste products don't accumulate to symptomatic levels. Like Stage 1, this stage requires evidence of kidney damage (proteinuria, structural changes) in addition to the reduced GFR—a GFR of 60 to 89 without other evidence of damage is considered a normal age-related decline and not classified as CKD.
What you'll notice: Typically still nothing symptom-wise. Some people may notice slightly more frequent urination, particularly at night (nocturia), as the kidneys' ability to concentrate urine begins declining subtly.
What's happening: The compensatory mechanisms from Stage 1 are beginning to reach their limits. Remaining nephrons are hyperfiltrating—filtering at rates above their designed capacity to maintain overall kidney function. This hyperfiltration, paradoxically, causes additional damage over time if not addressed, creating a cycle of progressive nephron loss.
What you should do: All Stage 1 measures apply with increased urgency. Blood pressure control becomes critical—uncontrolled hypertension is the single biggest accelerator of CKD progression at this stage. Dietary modifications should begin: moderate sodium restriction (below 2,300 mg daily), adequate but not excessive protein intake (0.8 grams per kilogram of body weight), and ensuring adequate hydration without fluid overload.
Cardiovascular risk assessment is important because CKD—even at early stages—significantly increases heart disease risk. The leading cause of death in CKD patients is cardiovascular disease, not kidney failure.
Stage 3: Moderate Function Loss (GFR 30-59)
Stage 3 is divided into 3a (GFR 45-59) and 3b (GFR 30-44) because the clinical implications differ substantially between these ranges. Stage 3 is where CKD typically first comes to medical attention because GFR in this range is often flagged on routine blood work.
What you'll notice: Stage 3a may still be asymptomatic or produce only mild, nonspecific symptoms. Stage 3b often brings noticeable changes: fatigue (from early anemia as the kidneys produce less erythropoietin), swelling in the hands and feet (from reduced sodium excretion and early fluid retention), changes in urine output or appearance, muscle cramps, and mild itching.
What's happening: The kidneys have lost 40 to 70 percent of their filtering capacity. Waste products—creatinine, urea, phosphorus, potassium—begin accumulating in the blood at measurable levels. The kidneys' endocrine functions are also declining: less erythropoietin production (causing anemia), less vitamin D activation (causing calcium/phosphorus imbalances that threaten bone health), and impaired acid-base regulation.
What you should do: Nephrology referral is strongly recommended at Stage 3b and should be considered at Stage 3a, especially if progression is rapid. Dietary modifications intensify: phosphorus restriction becomes important as the kidneys lose their ability to excrete excess phosphorus (limit processed foods, dark colas, dairy products, and processed meats). Potassium monitoring begins, though restriction isn't always necessary at this stage.
Medications may be added: SGLT2 inhibitors (originally diabetes medications) have shown remarkable kidney-protective effects in CKD patients regardless of diabetes status, reducing progression risk by 30 to 40 percent in clinical trials. Erythropoiesis-stimulating agents may be needed if anemia develops. Phosphate binders may be prescribed if phosphorus levels rise.
Avoid nephrotoxic substances strictly: NSAIDs, certain herbal supplements (especially those containing aristolochic acid), excessive doses of proton pump inhibitors, and unnecessary contrast dye for imaging studies.
Stage 4: Severe Function Loss (GFR 15-29)
Stage 4 is a critical juncture—kidney function has declined to the point where planning for potential kidney failure becomes necessary, even though kidney failure itself hasn't occurred yet.
What you'll notice: Symptoms become more prominent and harder to ignore. Significant fatigue from worsening anemia. Nausea and appetite changes from uremia (waste product accumulation). Swelling in the legs, ankles, and around the eyes. Difficulty concentrating or "brain fog." Increased susceptibility to infections. Bone pain from mineral and bone disorder. Changes in skin color and persistent itching. Metallic taste in the mouth.
What's happening: The kidneys have lost 70 to 85 percent of their function. Uremic toxins accumulate at levels that affect multiple organ systems. Fluid and electrolyte regulation becomes increasingly precarious. Acid-base balance requires intervention. Nutritional status often deteriorates due to appetite suppression and dietary restrictions.
What you should do: Intensive nephrology care is essential. Preparation for renal replacement therapy (dialysis or transplant) should begin even if it may not be needed imminently. This includes vascular access creation for hemodialysis (arteriovenous fistula placement, which needs months to mature before use), evaluation for kidney transplant candidacy and listing, education about dialysis modalities (hemodialysis vs peritoneal dialysis), and advanced care planning discussions.
Dietary protein restriction to 0.6 to 0.8 grams per kilogram becomes more important to reduce uremic toxin production while maintaining adequate nutrition. Potassium restriction is typically necessary. Fluid intake may need monitoring to prevent overload.
Medication adjustments are critical—many drugs are renally cleared and require dose reductions to prevent toxicity. A thorough medication review with dose adjustments should be performed regularly.
Stage 5: Kidney Failure (GFR Below 15)
Stage 5 represents kidney failure—also called end-stage kidney disease (ESKD). At this point, the kidneys can no longer sustain life without intervention.
What you'll notice: Without treatment, Stage 5 symptoms can be debilitating: severe fatigue and weakness, persistent nausea and vomiting, severe edema, shortness of breath from fluid overload or acidosis, confusion or difficulty thinking, seizures in extreme cases, and eventual cardiovascular collapse.
What's happening: Less than 15 percent of kidney function remains. The kidneys cannot maintain fluid balance, electrolyte levels, acid-base homeostasis, or adequate waste removal. Without replacement therapy, uremic toxins accumulate to life-threatening levels.
What you should do: Renal replacement therapy—either dialysis or kidney transplant—becomes necessary for survival. The timing of initiation depends on symptoms and laboratory values rather than GFR alone. Some patients begin dialysis at GFR of 10 to 12 mL/min when symptoms warrant, while others with fewer symptoms may delay until GFR approaches 5 to 7 mL/min under close monitoring.
Kidney transplantation is the preferred treatment for eligible patients because it provides superior quality of life and survival compared to dialysis. Living donor transplants from family members or altruistic donors offer the best outcomes and can sometimes be performed preemptively—before dialysis becomes necessary.
Hemodialysis filters the blood through an external machine, typically three times per week for four hours per session at a dialysis center, though home hemodialysis options are expanding.
Peritoneal dialysis uses the peritoneal membrane lining the abdominal cavity to filter blood. Dialysis solution is infused through a permanent catheter and drained after waste products have diffused across the membrane. It can be performed at home, daily, providing more lifestyle flexibility.
Conservative management (supportive care without dialysis) is an appropriate choice for some patients, particularly elderly individuals with multiple comorbidities and limited life expectancy, who may not benefit from the burden of dialysis and prefer comfort-focused care.
Slowing CKD Progression at Any Stage
Regardless of your current stage, the same fundamental principles slow CKD progression.
Blood pressure control is paramount. Hypertension accelerates nephron loss more than any other modifiable factor. The target for CKD patients with proteinuria is below 130/80 mmHg, achieved preferably with ACE inhibitors or ARBs that provide specific renal protection.
Blood sugar management in diabetic CKD patients directly slows progression. Each percentage point reduction in HbA1c reduces kidney complication risk significantly.
SGLT2 inhibitors have revolutionized CKD management. Drugs like dapagliflozin and empagliflozin reduce intraglomerular pressure, decrease proteinuria, and slow progression by 30 to 40 percent in trials—benefits that apply in both diabetic and non-diabetic CKD.
Dietary sodium restriction reduces blood pressure, decreases proteinuria, and enhances the effectiveness of ACE inhibitors and ARBs. Target less than 2,000 mg daily for most CKD patients.
Avoiding kidney-toxic substances prevents unnecessary damage to already compromised kidneys. This includes NSAIDs, certain herbal supplements, excessive contrast dye, and tobacco.
Maintaining physical activity improves cardiovascular fitness, blood pressure, blood sugar control, and quality of life across all CKD stages. Exercise does not harm the kidneys and provides measurable benefits even in advanced CKD.
The Importance of Early Detection
The most critical message about CKD staging is that early detection dramatically changes outcomes. A person diagnosed at Stage 1 or 2 who receives appropriate treatment may never progress to advanced disease. The same person diagnosed at Stage 4—having missed years of preventive opportunity—faces a much steeper climb.
If you have diabetes, hypertension, a family history of kidney disease, or are over 60, annual screening with a serum creatinine (for eGFR) and a urine albumin-to-creatinine ratio should be part of your routine medical care. These two simple tests can detect CKD years before symptoms appear, opening the window for interventions that can preserve your kidney function for a lifetime.
Sources and Further Reading
Health and Beyond uses reputable medical and scientific sources where possible. These links support or expand on the topics discussed above.
- KDIGO guidelineskdigo.org
